Abstract| Volume 23, ISSUE 3, PB12, March 2022

Download started.


Improving Osteoporosis Screening and Treatment in the Nursing Home

      In the United States 4% of men and 19% of older women have sustained a hip fracture: the clinical manifestation of osteoporosis. The rate of hip fractures among nursing home residents is 2 times higher than community-dwelling older adults. Fewer than half are treated with fracture prevention medications. The cost of treatment for hip fractures is 665 million dollars per year, from nursing home residents alone. Hip fractures are a large financial burden on the healthcare system and have a substantially increased risk of major morbidity and mortality in adults, especially in nursing home residents who may already have multi-morbidity. Approximately 50% of patients are unable to regain their prior level of function after a hip fracture and there is a 1-year mortality of 24%. Appropriate treatment for osteoporosis can decrease the risk of hip fracture. Short treatment durations are beneficial; 3 years of appropriate pharmacologic therapy has been demonstrated to reduce risk of fracture by 50%, with benefits seen as early as 1 year after initiation of treatment. Unfortunately, this is often not done in nursing homes despite being a vulnerable population.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of the American Medical Directors Association
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect